GlassScriptPhysician profile
Kyle Hopkins
NPI 1174045447
$4,527.23
in general payments reported to CMS, 2019-2025
14 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.56 · 2020: $56.79 · 2022: $998 · 2023: $2,032 · 2024: $709 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592 · Travel and Lodging: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.60 |
| Travel and Lodging | $827.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Implant Solutions, LLC | $1,193.91 | 2023-2025 | |
| Paragon 28, INC. | $1,131.32 | 2022-2023 | Apex 3d, Portfolio |
| Treace Medical Concepts, INC. | $867.97 | 2022 | |
| Medtronic, INC. | $439.04 | 2022-2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $438.55 | 2019-2024 | Grafix Pl, Stravix Pl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Nevro Corp. | $173.65 | 2023 | Senza |
| Mimedx Group, INC. | $147.80 | 2025 | |
| Kci USA, INC. | $35.50 | 2019 | |
| Fidia Pharma USA INC. | $23.27 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.35 | 2023 | |
| Zimmer Biomet Holdings, INC. | $17.25 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $14.75 | 2024 | Zilretta, Iovera, Exparel |
| Acell, INC. | $13.33 | 2020 | |
| Stryker Corporation | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Hopkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.